5020.0: Wednesday, October 24, 2001 - Board 2

Abstract #27848

Long-term medical follow-up of individuals exposed to high levels of lead

Michael R. Spence, MD, MPH1, Patricia Butterfield, PhD, RN2, Vivian Rush, MD, MPH3, Greg Thomas, MPH3, Spear Rebecca, RN4, Susan Myers-Clack, MS, CHES4, Kelly Grossman, BS4, and amanda amidon4. (1) Bunker Hill Medical Monitoring Program, Montana Department of Public Health and Human Services, P.O. Box 202951, Cogswell Building, Helena, MT 59620, 406-444-1286, mspence@state.mt.us, (2) College of Nursing, Montana State University Bozeman, P.O. Box 173560, Sherrick Hall, Bozeman, MT 59717, (3) Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd. E-33, Atlanta, GA, (4) College of Nursing, Montana State University, 201 Sherrick Hall, Montana State University-Bozeman, Bozeman, MT 59717

The Bunker Hill Medical Monitoring Program (BHMMP) is a public health service providing screening, education, and referrals for eligible people (EP) exposed to lead while living near or working for the Idaho Bunker Hill lead smelter between 1973 and 1981. Blood lead levels in this community were documented up to 164 µg/dL. This exposure increased the population’s risk for developing lead-related health conditions. Presently, an unknown number of these EPs reside in Montana and the BHMMP is identifying and providing them with free screening for two lead-related conditions, hypertension and renal disease. Methods: EPs had an extensive exposure questionnaire obtained and they were clinically evaluated for evidence of hypertension (HBP). Blood and urine specimens were obtained to evaluate renal function. Results: 27 EPs have been screened to date and an additional 152 are involved in the screening process. Screened individuals include 14 men and 13 women with a mean age of 47.2 years and range of 27-79 years. HBP was found in 6/27 (22%), and 2/27 (7.4%) have evidence of renal disease. Discussion: This program assesses the potential, long-term, medical impact of lead exposure 20-25 years after the occurrence. Results of screening for the entire population will be presented and discussed.

Learning Objectives: 1. Describe the epidemiology of this population. 2. List the medical consequences of lead exposure. 3. Discuss the long-term follow-up of heavy metal exposures.

Keywords: Lead, Chronic Diseases

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 129th Annual Meeting of APHA